| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 48.8658 | 45 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.1374 | 37 |
| GSM780709 | Untreated after 4 days (C3_1) | 41.0673 | 10 |
| GSM780719 | Untreated after 4 days (C1_2) | 44.5048 | 25 |
| GSM780720 | Untreated after 4 days (C2_2) | 49.9067 | 48 |
| GSM780721 | Untreated after 4 days (C3_2) | 47.8102 | 40 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 60.3068 | 65 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 45.3626 | 29 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 54.075 | 58 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 50.6543 | 50 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 45.6016 | 30 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 45.7714 | 31 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 42.8877 | 17 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 53.3322 | 57 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 47.6742 | 40 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 46.5332 | 35 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 43.3225 | 19 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 42.2713 | 14 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 51.8 | 53 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 47.1336 | 37 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 50.3404 | 50 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 40.9787 | 9 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 47.8518 | 40 |